Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
September 21, 2024 04:15 ET
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in treating schizophrenia, including TEV-‘749Currently, there is no...
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)
September 21, 2024 04:10 ET
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and...
Nayax to Partner With Five Star's Feeding the Future Charitable Golf Tournament on September 23, 2024
September 19, 2024 07:00 ET
|
Nayax Ltd.
Nayax is proud to be a sponsor of Feeding the Future’s Golf Classic for the fourth consecutive year.
SaverOne Announces New Pilot with Malta Public Transport Company
September 18, 2024 08:00 ET
|
SaverOne 2014 Ltd.
Petah Tikvah, Israel, Sept. 18, 2024 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company that develops and sells advanced transportation safety solutions, today...
Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24
September 18, 2024 06:30 ET
|
Purple Biotech Ltd.
High CEACAM1 and low PDL1 expression in tumors, as well as their combination identified as potential biomarkers associated with improved overall survival (OS) of pancreatic ductal adenocarcinoma...
SaverOne Launches Four Pilot Projects with Customers of Volvo Buses Mexico
September 17, 2024 08:00 ET
|
SaverOne 2014 Ltd.
Petah Tikvah, Israel, Sept. 17, 2024 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company engaged in disruptive transportation safety solutions, today announced...
BrainsWay Announces Significant Expansion on U.S. East Coast
September 16, 2024 07:30 ET
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
Gilat Satellite Networks Awarded Over $5M in Support of the US Department of Defense
September 16, 2024 07:03 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced...
Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
September 16, 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
Study will aim to establish safety and clinical efficacy PETACH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology...
Nayax Partners with Adyen to Globally Expand Electric Vehicle Charging and Automated Self-Service Payments Infrastructure
September 16, 2024 07:00 ET
|
Nayax Ltd.
HERZLIYA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments and loyalty platform designed to help merchants scale their...